In This Section

Recent Press Releases

November 7, 2016

VANCOUVER, British Columbia, Nov. 07, 2016 -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) (“QLT”) announced today certain matters relating to the previously announced transactions (the “Transactions”) contemplated in connection with an agreement and plan of merger dated as of June 14, 2016 (the “Merger Agreement”) involving QLT and Aegerion Pharmaceuticals, Inc. (“Aegerion”).

Shareholder Approval

November 3, 2016

CAMBRIDGE, Mass., Nov. 03, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced the appointment of John J. Orloff, M.D., as executive vice president, head of research and development, effective immediately.